Mikhail A. Boldyrev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mikhail A. Boldyrev has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- A. D. Belova
The Shumakov National Medical Research Center of Transplantology and Artificial Organs, 123182 Moscow, Russia
1 shared publication A. R. Monakhov
Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University
1 shared publicationA.A. Shiryayev
1 shared publication- A.L. Skugarev
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
1 shared publication A.V. Semenkov
1 shared publication- Aleksey Vladimirovich Semenkov
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
1 shared publication
Latest Publications
- Open Access
- 19 August 2026
- Published by MDPI AG in Methods and Protocols
- Vol. 9 (4) , 122
Suitability of a Fluorescence Method for Flavin Mononucleotide Determination in Modified HTK-Based Perfusion Solutions During Hypothermic Oxygenated Perfusion of Liver Grafts
A comprehensive assessment of allograft quality is essential for predicting successful transplantation and graft survival. Elevated levels of flavin mononucleotide (FMN) in perfusate obtained during hypothermic oxygenated perfusion (HOPE) may serve as a promising predictor of early graft dysfunction and post-transplant complications. The aim of this study was to evaluate the feasibility of applying an FMN determination method to HTK-based perfusion solutions used during liver machine perfusion. The spectrofluorimetric method for FMN determination in modified HTK perfusion solution (modHTK) was evaluated for the following parameters: linearity, accuracy, repeatability, reproducibility, and stability. The study demonstrated the suitability of the quantitative FMN determination method for modHTK solution used during HOPE of liver grafts.
- 19 August 2026
- Published by MDPI AG in Methods and Protocols
- Vol. 9 (4) , 122
Open AccessSuitability of a Fluorescence Method for Flavin Mononucleotide Determination in Modified HTK-Based Perfusion Solutions During Hypothermic Oxygenated Perfusion of Liver Grafts
A comprehensive assessment of allograft quality is essential for predicting successful transplantation and graft survival. Elevated levels of flavin mononucleotide (FMN) in perfusate obtained during hypothermic oxygenated perfusion (HOPE) may serve as a promising predictor of early graft dysfunction and post-transplant complications. The aim of this study was to evaluate the feasibility of applying an FMN determination method to HTK-based perfusion solutions used during liver machine perfusion. The spectrofluorimetric method for FMN determination in modified HTK perfusion solution (modHTK) was evaluated for the following parameters: linearity, accuracy, repeatability, reproducibility, and stability. The study demonstrated the suitability of the quantitative FMN determination method for modHTK solution used during HOPE of liver grafts.
- Open Access
- 10 January 2026
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 27 (4) , 8-23
Combined machine perfusion and ischemia-free implantation of livers from high-risk donors: fi rst experience in Russia
Objective: to assess the effi cacy and safety of combining sequential dual hypothermic oxygenated machine perfusion (DHOPE), controlled oxygenated rewarming (COR), and normothermic machine perfusion (NMP) with ischemia-free liver implantation (IFLI) for transplants obtained from high-risk expanded criteria donors (ECDs). Materials and methods . The study presents two cases of liver transplantation performed using the combined DHOPE-COR-NMP-IFLI protocol in May and June 2025 at the Shumakov National Medical Research Center of Transplantology and Artifi cial Organs. Liver allografts were procured from brain-dead ECDs. Perfusion was carried out using a cardiopulmonary bypass (CPB) machine following a period of static cold storage (SCS). The allografts were subsequently transplanted into recipients under continuous NMP after meeting viability criteria. The reproducibility and safety of the IFLI approach within the combined protocol were evaluated through descriptive analysis of donor characteristics, perfusion parameters, and intra- and postoperative outcomes in the recipients. Results . In both cases, the grafts met the established viability criteria despite pronounced macrovesicular steatosis (95% and 80%, respectively). In Case No. 1, all viability parameters were achieved after 4 hours of NMP. In Case No. 2, lactate clearance was suboptimal, reaching the acceptable threshold of 4.1 mmol/L only after 6 hours of perfusion. No post-perfusion syndrome or hemodynamic instability occurred in either recipient during graft reperfusion. Both recipients met the criteria for early allograft dysfunction, with cytolysis levels of 6562.9 and 1610.4 U/L, and 3822 and 2662 U/L, respectively. The recipients were discharged on postoperative days 17 and 34 without serious complications (Clavien–Dindo ≥IIIb). At 4- and 5-month follow-up, no transplant- or preservation-related complications were observed. Conclusion . The combined application of sequential machine perfusion (DHOPE-COR and NMP) with IFLI is a safe and eff ective dynamic preservation strategy. This approach enables the successful use of liver grafts from ECDs by minimizing ischemia–reperfusion injury.
- 10 January 2026
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 27 (4) , 8-23
Open AccessCombined machine perfusion and ischemia-free implantation of livers from high-risk donors: fi rst experience in Russia
Objective: to assess the effi cacy and safety of combining sequential dual hypothermic oxygenated machine perfusion (DHOPE), controlled oxygenated rewarming (COR), and normothermic machine perfusion (NMP) with ischemia-free liver implantation (IFLI) for transplants obtained from high-risk expanded criteria donors (ECDs). Materials and methods . The study presents two cases of liver transplantation performed using the combined DHOPE-COR-NMP-IFLI protocol in May and June 2025 at the Shumakov National Medical Research Center of Transplantology and Artifi cial Organs. Liver allografts were procured from brain-dead ECDs. Perfusion was carried out using a cardiopulmonary bypass (CPB) machine following a period of static cold storage (SCS). The allografts were subsequently transplanted into recipients under continuous NMP after meeting viability criteria. The reproducibility and safety of the IFLI approach within the combined protocol were evaluated through descriptive analysis of donor characteristics, perfusion parameters, and intra- and postoperative outcomes in the recipients. Results . In both cases, the grafts met the established viability criteria despite pronounced macrovesicular steatosis (95% and 80%, respectively). In Case No. 1, all viability parameters were achieved after 4 hours of NMP. In Case No. 2, lactate clearance was suboptimal, reaching the acceptable threshold of 4.1 mmol/L only after 6 hours of perfusion. No post-perfusion syndrome or hemodynamic instability occurred in either recipient during graft reperfusion. Both recipients met the criteria for early allograft dysfunction, with cytolysis levels of 6562.9 and 1610.4 U/L, and 3822 and 2662 U/L, respectively. The recipients were discharged on postoperative days 17 and 34 without serious complications (Clavien–Dindo ≥IIIb). At 4- and 5-month follow-up, no transplant- or preservation-related complications were observed. Conclusion . The combined application of sequential machine perfusion (DHOPE-COR and NMP) with IFLI is a safe and eff ective dynamic preservation strategy. This approach enables the successful use of liver grafts from ECDs by minimizing ischemia–reperfusion injury.
- 1 January 2022
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 10 (1)
Clinical significance of pancreatic ectopia in various organs (literature review and cases of symptomatic and asymptomatic course)
Клиническое значение эктопии поджелудочной железы в различные органы (обзор литературы и клинические наблюдения симптомного и бессимптомного течения)
- 1 January 2022
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 10 (1)
Clinical significance of pancreatic ectopia in various organs (literature review and cases of symptomatic and asymptomatic course)
Клиническое значение эктопии поджелудочной железы в различные органы (обзор литературы и клинические наблюдения симптомного и бессимптомного течения)